Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Open House Medicinal Practice Treaties Tofacitinib, Atc L04af01 2025-12-13
Germany Open House Pharmaceutical Dact Treaties Brinzolamid And Brimonidin, Atc S01ec24 2025-12-13
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Felbamat, Atc N03ax10 For The Period 01.08.2025 - 31.07.2027 2025-12-13
Germany Open House Pharmaceutical Dact Treaties Brinzolamid And Brimonidin, Atc S01ec24 2025-12-13
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Ponesimod, Atc L04ae04 For The Period 01.08.2025 - 31.07.2027 2025-12-13
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Melatonin (exclusively 1mg And 5mg), Atc N05ch01 For The Period 01.08.2025 - 31.2012027 2025-12-13
Germany Completion Not Excl. Pharmaceutical Discount Club. According To § 130a Para. 8 Sgb V In The Way Of An Open House Model To The Active Ingredient Pegintereron Beta1a (atccode According To Who 2025-12-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To Section 130a Paragraph 8 Sgb V For The Active Ingredient Nomegestrol + Estradiol, Atc G03aa14 For The Period 01.08.25 - 31.07.27 (plus Extension Option 1x12 Months) Vgv Tender Dak-gesundheit 2025-12-13
Germany Open House Medicinal Department Departments Epinephrin, Atc C01ca24 2025-12-14
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V To The Active Ingredient Iron (iii) Derisomaltosis, Atc B03ac08 For The Time 01.08.2025 31.07.2027 2025-12-14
Whats app